| Stock | Role | Class | Num Shares | Value | Price $ | Report Date | Ownership |
|---|---|---|---|---|---|---|---|
| Inhibikase Therapeutics, Inc. | Director | Stock Option (Right to Buy) | 22.6K | Feb 14, 2025 | Direct |
| Symbol | Company | Period | Transactions | Value $ | Form Type | Date Filed | Role |
|---|---|---|---|---|---|---|---|
| IKT | Inhibikase Therapeutics, Inc. | Feb 14, 2025 | 1 | $0 | 4 | Feb 19, 2025 | Director |
| IKT | Inhibikase Therapeutics, Inc. | Jan 21, 2025 | 12 | $0 | 4 | Jan 22, 2025 | Director |
| IKT | Inhibikase Therapeutics, Inc. | Jan 3, 2025 | 3 | $0 | 4 | Jan 7, 2025 | Director |
| IKT | Inhibikase Therapeutics, Inc. | Jul 16, 2024 | 1 | $0 | 4 | Jul 18, 2024 | Director |
| IKT | Inhibikase Therapeutics, Inc. | Jun 30, 2023 | 1 | $0 | 4 | Jul 5, 2023 | Director |
| IKT | Inhibikase Therapeutics, Inc. | Jun 24, 2022 | 1 | $0 | 4 | Jun 28, 2022 | Director |
| IKT | Inhibikase Therapeutics, Inc. | Jun 25, 2021 | 1 | $0 | 4 | Jun 29, 2021 | Director |